Aspirin

Aspirin is effective in ischemic stroke because it lowers the risk of clot progression and prevents new clots from forming, which reduces the chance of stroke worsening or recurrence. Studies have shown that early use of aspirin after an ischemic stroke decreases the likelihood of another stroke and modestly improves overall recovery outcomes. Over the long term, continuing aspirin helps maintain protection by reducing the risk of future vascular events such as recurrent stroke and heart attack. Its proven benefit in both the acute and preventive phases makes it one of the most reliable and widely used therapies in stroke care.

Treatment Type: Over the Counter Medication

Treatment Class: Antiplatelet

Treatment Modality: Oral

Aspirin

Review Summary

5.0

1 Reviews

Preferred by 1 Reviewers

Based on the review by Dr. Curbside, Aspirin is highly effective in treating Ischemic Cerebrovascular Accident, particularly in secondary prevention. It is well-established, evidence-based, widely available, and cost-effective for reducing recurrent stroke events.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
5.0
1 = Very Expensive 5 = Very Affordable

5.0

Very Affordable
Relief Speed
2.0
1 = No Relief 5 = Immediate Relief

2.0

Slow Relief
Side Effects
4.0
1 = Intolerable Effect 5 = No Effect

4.0

Mild Effect
Treatment Line
5.0
1 = Third-line or more 5 = First-line

5.0

First-line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

5.0

1 Reviews
5
100%
4
0%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review by Dr. Curbside, Aspirin is highly effective in treating Ischemic Cerebrovascular Accident, particularly in secondary prevention. It is well-established, evidence-based, widely available, and cost-effective for reducing recurrent stroke events.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
1 month ago
Aspirin is the baseline antiplatelet therapy for ischemic stroke, with strong evidence supporting its role in preventing recurrent strokes. It has been well studied over decades and consistently improves outcomes in secondary prevention, but it is not used to treat the acute stroke itself. In addition, aspirin is widely available and inexpensive, making it a reliable and accessible cornerstone of long-term stroke care.
#VeryAffordable #CoveredByInsurance #SlowRelief #MildEffect #First-line #Preventative
View Professional Disclosures

Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All